Sheffield, United Kingdom

Franco Di Giovine


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franco Di Giovine: Innovator in Asthma Prediction

Introduction

Franco Di Giovine is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of medical science, particularly in the prediction of chronic obstructive airway disorders such as asthma. His innovative approach has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Franco Di Giovine holds a patent for a method and kit for predicting susceptibility to asthma. This invention provides a novel method for the early prediction of a propensity to develop chronic obstructive airway disorders. The method involves detecting the presence of specific alleles of an IL-1B haplotype, particularly the IL-1b (+3954) and the IL-1B (-511) loci. The presence of allele 2 at the IL-1b (+3954) locus indicates an increased risk for chronic obstructive airway disorders. Additionally, the presence of allele 2 at the IL-1B (-511) locus suggests susceptibility to more severe expressions of these disorders.

Career Highlights

Franco Di Giovine is associated with Interleukin Genetics, Inc., where he continues to work on innovative solutions in the field of genetics and respiratory health. His research focuses on understanding the genetic factors that contribute to asthma and other airway disorders.

Collaborations

Franco has collaborated with notable professionals in his field, including Gordon W. Duff and Peter John Barnes. These collaborations have furthered research and development in the area of asthma prediction and management.

Conclusion

Franco Di Giovine's work in predicting susceptibility to asthma represents a significant advancement in medical science. His innovative methods and collaborations highlight the importance of genetic research in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…